Unlikely Advocate Emerges for Psychedelic Treatment
Former Texas Governor and U.S. Energy Secretary Rick Perry has taken on a surprising new role as a leading advocate for ibogaine, a powerful psychedelic derived from a West African shrub. Known for his long tenure in conservative politics, Perry's shift to championing a substance currently classified as illegal in the United States has caught the attention of many. His journey into this unconventional cause began nearly two years ago, driven by a personal conviction in the drug's potential to address severe issues like addiction, trauma, and brain injury.
Perry has publicly declared his dedication to this mission, stating, 'I'm dedicating my life to fighting for a psychedelic drug.' His advocacy is rooted in the belief that ibogaine can offer transformative benefits, particularly for veterans struggling with PTSD. As chairman of Americans for Ibogaine, Perry is actively working to raise awareness and push for research, traveling across the country to urge state leaders to support clinical studies.
Texas Leads with Historic Funding for Ibogaine Research
In a groundbreaking move, Texas lawmakers approved $50 million in funding for clinical trials to study ibogaine as a treatment for addiction and brain trauma. This grant, noted as the largest of its kind by any government, received bipartisan support, including from Perry himself and current state leaders. The decision comes at a time when Texas is also considering stricter regulations on other substances like THC, highlighting a complex landscape for drug policy in the state.
Perry's influence in securing this funding cannot be understated. His persistent lobbying and public statements have helped frame ibogaine as a potential game-changer in mental health treatment. 'The results of that study are nothing short of miraculous when it comes to the way in which Ibogaine has been revealed to have significant impact,' Perry remarked during a podcast discussion, emphasizing the urgency of making this treatment accessible.
National Momentum and Future Prospects for Ibogaine
Beyond Texas, other states like Colorado and Oregon are also exploring reforms in psychedelic policy, with over 20 states showing interest in similar initiatives. At the 2025 Psychedelic Science conference, ibogaine therapy was a central topic, with endorsements from figures like Perry amplifying its visibility. However, some advocates express concern about the potential exploitation of this plant medicine if not regulated carefully.
Perry's advocacy aligns with broader national conversations, including support from figures like Robert F. Kennedy Jr., the U.S. Secretary of Health and Human Services, who has voiced openness to plant-based therapies for veterans. Perry hopes to see ibogaine removed from Schedule I classification, arguing, 'With 20-plus veterans a day killing themselves, yet we have a compound that could help, we must act.' As research progresses, the future of ibogaine therapy remains a topic of intense debate and hope, with Perry at the forefront of this evolving field.